Sanofi SA (SNY)
52.94
-0.33
(-0.62%)
USD |
NASDAQ |
Nov 04, 16:00
52.93
-0.01
(-0.02%)
After-Hours: 20:00
Sanofi Price to Book Value: 1.703 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 1.714 |
| October 31, 2024 | 1.702 |
| October 30, 2024 | 1.720 |
| October 29, 2024 | 1.732 |
| October 28, 2024 | 1.749 |
| October 25, 2024 | 1.748 |
| October 24, 2024 | 1.675 |
| October 23, 2024 | 1.702 |
| October 22, 2024 | 1.714 |
| October 21, 2024 | 1.727 |
| October 18, 2024 | 1.768 |
| October 17, 2024 | 1.765 |
| October 16, 2024 | 1.752 |
| October 15, 2024 | 1.756 |
| October 14, 2024 | 1.767 |
| October 11, 2024 | 1.768 |
| October 10, 2024 | 1.762 |
| October 09, 2024 | 1.775 |
| October 08, 2024 | 1.765 |
| October 07, 2024 | 1.762 |
| October 04, 2024 | 1.785 |
| October 03, 2024 | 1.787 |
| October 02, 2024 | 1.81 |
| October 01, 2024 | 1.844 |
| September 30, 2024 | 1.854 |
| Date | Value |
|---|---|
| September 27, 2024 | 1.855 |
| September 26, 2024 | 1.834 |
| September 25, 2024 | 1.823 |
| September 24, 2024 | 1.854 |
| September 23, 2024 | 1.848 |
| September 20, 2024 | 1.854 |
| September 19, 2024 | 1.874 |
| September 18, 2024 | 1.849 |
| September 17, 2024 | 1.831 |
| September 16, 2024 | 1.844 |
| September 13, 2024 | 1.838 |
| September 12, 2024 | 1.826 |
| September 11, 2024 | 1.849 |
| September 10, 2024 | 1.870 |
| September 09, 2024 | 1.882 |
| September 06, 2024 | 1.857 |
| September 05, 2024 | 1.874 |
| September 04, 2024 | 1.883 |
| September 03, 2024 | 1.851 |
| August 30, 2024 | 1.810 |
| August 29, 2024 | 1.812 |
| August 28, 2024 | 1.805 |
| August 27, 2024 | 1.812 |
| August 26, 2024 | 1.810 |
| August 23, 2024 | 1.808 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.260
Minimum
Sep 27 2022
1.990
Maximum
Jun 22 2020
1.670
Average
1.687
Median
Aug 05 2021
Price to Book Value Benchmarks
| AstraZeneca PLC | 5.605 |
| Eli Lilly and Co | 53.75 |
| Pfizer Inc | 1.794 |
| Regeneron Pharmaceuticals Inc | 3.106 |
| Novavax Inc | -- |
Price to Book Value Related Metrics
| PE Ratio | 26.82 |
| PS Ratio | 2.498 |
| Price | 52.94 |
| Earnings Yield | 3.73% |
| Market Cap | 132.70B |
| Operating PE Ratio | 11.54 |
| Normalized PE Ratio | 16.52 |